ZURA compared with WHWK: revenue, margins and what each company keeps, and the suppliers and customers both name

ZURAZura Bio Ltd

Mkt capRevenueRevenue

WHWKWhitehawk Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ZURAZura Bio Ltd

WHWKWhitehawk Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ZURA2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±74.6%▲+19.94%×0.27

Q2 FY26±56.6%▼−1.24%×0.02

WHWK1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±42.2%▲+15.48%×0.37

= impliedZURA realized, solidWHWK realized, hatchedOne scale, both sides: full bar = 75%× = |realized| ÷ impliedSource: market data

ZURAZura Bio Ltd

4.05▲+5.06%· post 4.03

Mkt cap$516.0MRevenue—Revenue—

WHWKWhitehawk Therapeutics, Inc.

3.23▼−2.08%· post 3.23

ClosedOct 30 '26

Mkt cap$184.7MRevenue$7MQ1 FY25Revenue$26MFY24

Compare

ClosedOct 30 '26

ZURAZura Bio Ltd

WHWKWhitehawk Therapeutics, Inc.

4.05▲+5.06%post 4.03

Price

3.23▼−2.08%post 3.23

$516.0M

Mkt cap

$184.7M

—

Revenue

$7MQ1 FY25

—

Revenue

$26MFY24

ZURA4.05▲+5.06%vsWHWK3.23▼−2.08%ClosedOct 30 '26